No GRASE For Ibuprofen, No Future In OTC Internal Analgesic Monograph
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Nonprescription products containing ibuprofen can now only be marketed in the US through NDAs. No companies took advantage of a proposed ibuprofen addition to the the internal analgesic, antipyretic and antirheumatic OTC monograph, issued in 2002.